The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

The real-world benefit of novel androgen receptor-targeting agents (ARTA) before and after docetaxel in CRPC with bone metastases in Japan: A subanalysis of the PROSTAT-BSI, a prospective observational study before and after approval of novel ARTAs.

Atsushi  Mizokami

No Relationships to Disclose

Rie  Fukuda

No Relationships to Disclose

Taiki  Kamijima

No Relationships to Disclose

Kouji  Izumi

Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Ono Pharmaceutical

Research Funding - AstraZeneca; Chugai Pharma; MSD

Expert Testimony - Bayer

Yoshifumi  Kadono

No Relationships to Disclose

Kenichi  Nakajima

No Relationships to Disclose